BiotechTube
Home/Tetraneuron/José M. Frade, PhD
JM

José M. Frade, PhD

Co-Founder and Chief Scientific Officer

Tetraneuron

Therapeutic Areas

Alzheimer's DiseaseParkinson's DiseaseNeurodegenerative Diseases

Tetraneuron Pipeline

DrugIndicationPhase
E2F4-targeted Gene TherapyAlzheimer's DiseasePre-clinical

Leadership Team at Tetraneuron

ÁL
Ángel Lucio Pereira
CEO
MN
Manuel Nuñez González
Chairman & Co-Founder
ÁP
Álvaro Pascual-Leone, MD, PhD
Chief Medical Officer
MC
Mari Carmen Álvarez, PhD
Managing Director
MM
Mar Municio, PhD
R&D Director
NL
Noelia López Sánchez, PhD
Technical Director
View full Tetraneuron profile